Research Evaluates Osteoarthritis Hydrogel for Mobility
New research from Madison tests an injectable hydrogel designed to improve joint mobility and tissue response.
Updated on Oct. 15, 2026 in Veterinary Medicine
Live Poll
Is medical research on animals to treat joint conditions justified by the potential health benefits?
PetVivo has released new research on a collagen-elastin hydrogel used for osteoarthritis, conducted in collaboration with the Wisconsin National Primate Research Center in Madison. The studies evaluate the mobility improvements and tissue responses in rhesus macaques treated with the Spryng hydrogel.
Why it matters
These findings provide insight into how intra-articular hydrogels function within joint tissues to potentially manage osteoarthritis. By tracking how long the material remains in the synovial membrane, researchers are building a clearer picture of treatment efficacy and safety.
The mobility study observed an average walking speed increase of 0.22 meters per second in 18 macaques at weeks one, two, and three. A second study of four macaques confirmed hydrogel incorporation into the synovial membrane by day 11, with material still present at day 28.
The players
PetVivo
A biomedical device company focused on developing technology for the treatment of osteoarthritis in animals and humans.
Wisconsin National Primate Research Center
A research facility at the University of Wisconsin-Madison that conducts studies on human and animal health.
The details
The Spryng hydrogel with OsteoCushion Technology is administered through an intra-articular injection to the joint. Researchers used a combination of walking speed tests, accelerometry, reach testing, and goniometry to evaluate physical function. Histologic evaluation demonstrated that the hydrogel integrates into the synovial membrane, causing minimal inflammatory response, before appearing to reduce in volume by day 54.
Timeline
October 21-24, 2026: APV Workshop in Houston, Texas.
October 25-29, 2026: AALAS National Meeting in Houston, Texas.
November 14-17, 2026: ACVP Annual Meeting in Indianapolis, Indiana.
The Home Front
This research builds on the ongoing development of injectable therapies for osteoarthritis, a condition commonly managed in both domestic pets and humans. It follows established trends in veterinary medicine toward less invasive, intra-articular interventions for long-term mobility support.
While these studies were performed in a research setting, owners of pets with diagnosed osteoarthritis should consult their veterinarian regarding current treatment options. Discuss whether intra-articular therapies or other joint-support technologies are appropriate for your pet's specific condition.
The takeaway
The study suggests that the tested hydrogel integrates safely into joint tissue while providing measurable improvements in walking speed. Pet owners should maintain records of their pet's mobility and clinical history to facilitate better treatment discussions with their veterinarian.
Further reading
Learn more about the latest developments in joint health and care in the Veterinary Medicine section.
Source note: This article includes information reported by The Manila times.
Live Poll
Is medical research on animals to treat joint conditions justified by the potential health benefits?
